These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7909438

  • 21. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K, Cho-Chung YS.
    Cancer Res; 1993 Feb 15; 53(4):868-72. PubMed ID: 8428367
    [Abstract] [Full Text] [Related]

  • 22. Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells.
    Shen M, Feng Y, Ge B, Wu Z, Zhu M.
    Chin Med J (Engl); 2001 Jul 15; 114(7):735-7. PubMed ID: 11780339
    [Abstract] [Full Text] [Related]

  • 23. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 24. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF, Angioli R, Unal AD, Sevin BU, Madrigal M, Estape R, Averette HE.
    Gynecol Oncol; 1997 Jul 27; 66(1):94-102. PubMed ID: 9234928
    [Abstract] [Full Text] [Related]

  • 25. HER2/neu antisense targeting of human breast carcinoma.
    Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA.
    Oncogene; 2000 Dec 11; 19(53):6138-43. PubMed ID: 11156527
    [Abstract] [Full Text] [Related]

  • 26. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines.
    Grooteclaes M, Pasleau F, Dijkmans H, Berzi P, Albert A, Winkler-Gol R.
    Cancer Res; 1994 Aug 01; 54(15):4193-9. PubMed ID: 7913414
    [Abstract] [Full Text] [Related]

  • 27. Rapid induction of Jak2 and Sp1 in T cells by phosphorothioate oligonucleotides.
    Too CK.
    Antisense Nucleic Acid Drug Dev; 1998 Apr 01; 8(2):87-94. PubMed ID: 9593046
    [Abstract] [Full Text] [Related]

  • 28. c-erbB2 amplification and overexpression in human tumors.
    Lofts FJ, Gullick WJ.
    Cancer Treat Res; 1992 Apr 01; 61():161-79. PubMed ID: 1360230
    [Abstract] [Full Text] [Related]

  • 29. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D, Brixel LR, Schmidtke P, Maringer M, Schiffer IB, Heimerdinger CK, Hengstler JG, Fritz G, Bockamp EO, Prawitt D, Zabel BU, Spangenberg C.
    Cancer Res; 2005 Feb 01; 65(3):840-9. PubMed ID: 15705882
    [Abstract] [Full Text] [Related]

  • 30. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM, Lau KM, Mok SC, Syed V.
    Oncogene; 2003 Jul 03; 22(27):4243-56. PubMed ID: 12833147
    [Abstract] [Full Text] [Related]

  • 31. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines.
    Riedel F, Götte K, Goessler U, Sadick H, Hörmann K.
    Anticancer Res; 2004 Jul 03; 24(4):2179-83. PubMed ID: 15330158
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
    Soldatenkov VA, Dritschilo A, Wang FH, Olah Z, Anderson WB, Kasid U.
    Cancer J Sci Am; 1997 Jul 03; 3(1):13-20. PubMed ID: 9072302
    [Abstract] [Full Text] [Related]

  • 33. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW, Roh H, Pippin JA, Drebin JA.
    J Surg Res; 2001 Nov 03; 101(1):16-20. PubMed ID: 11676549
    [Abstract] [Full Text] [Related]

  • 34. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 03; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 35. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
    Herbert JM, Guy AF, Lamarche I, Mares AM, Savi P, Dol F.
    J Cell Physiol; 1997 Feb 03; 170(2):106-14. PubMed ID: 9009139
    [Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 37. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 38. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J.
    Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117
    [Abstract] [Full Text] [Related]

  • 39. Enhanced expression of hepatocyte growth factor and c-Met mRNAs in isografts in experimental rat liver transplants.
    Ogasawara H, Tanabe M, Furuya T, Murase N, Iwatsuki S, Nakamura T, Katyal SL, Shinozuka H.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):149-51. PubMed ID: 7679809
    [No Abstract] [Full Text] [Related]

  • 40. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
    Skutella T, Stöhr T, Probst JC, Ramalho-Ortigao FJ, Holsboer F, Jirikowski GF.
    Horm Metab Res; 1994 Oct 15; 26(10):460-4. PubMed ID: 7851868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.